Clive Prestidge

Professor Clive Prestidge leads the Cancer Research Institute’s Nanostructure and Drug Delivery research group in the Centre for Cancer Diagnostics and Therapeutics. The Group has a primary focus on nano-structured drug delivery systems and interfacial science applied to pharmaceutical formulation and delivery.

The Nanostructure and Drug Delivery Group uses pharmaceutical science and nanomedicine approaches to provide drug delivery solutions to challenging therapeutic molecules, and to advance new medicines in such fields as cancer chemotherapy drugs, anti-infective agents, anti-psychotics and cardiovascular drugs.